Updated Jul 16, 2026 · Last SEC filing 2026-07-10
PALISADE BIO, INC. (PALI) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-10. 2 Form 8-K material event filings were reported by PALI in the last 90 days. 2 Form 144 notices of proposed sale were filed for PALI stock. InsiderAlpha tracks every PALI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Biological Products, (No Diagnostic Substances) (SIC 2836) |
|---|---|
| SEC CIK | 0001357459 |
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-10 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Baltera Robert Jr. | Director | P — Open-market purchase | 25.0K | $1.96 | $49K | SEC | |
| Baltera Robert Jr. | Director | P — Open-market purchase | 20.0K | $1.99 | $40K | SEC | |
| Finley John David | CEO, CFO | S — Open-market sale | 146.8K | $2.07 | $303K | SEC | |
| Baltera Robert Jr. | Director | P — Open-market purchase | 30.0K | $2.03 | $61K | SEC | |
| Finley John David | CEO, CFO | M — Option exercise | 133 | $0.70 | $93 | SEC | |
| Jones Mitchell Lawrence | Chief Medical Officer | S — Open-market sale | 51.9K | $2.05 | $107K | SEC | |
| Jones Mitchell Lawrence | Chief Medical Officer | M — Option exercise | 131.2K | — | — | SEC | |
| Baltera Robert Jr. | Director | P — Open-market purchase | 20.0K | $2.05 | $41K | SEC | |
| Finley John David | CEO, CFO | M — Option exercise | 335.2K | — | — | SEC | |
| Baltera Robert Jr. | Director | P — Open-market purchase | 10.0K | $1.98 | $20K | SEC | |
| Baltera Robert Jr. | Director | P — Open-market purchase | 20.0K | $1.98 | $40K | SEC | |
| Wei Binxian | Director | A — Grant or award | 592.3K | — | — | SEC | |
| Zwick Jordan Michael | Director | A — Grant or award | 336.9K | — | — | SEC | |
| Williams Donald Allen | Director | A — Grant or award | 1.50M | — | — | SEC | |
| Williams Donald Allen | Director | M — Option exercise | 60.7K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for PALISADE BIO, INC. (PALI). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Baltera Robert Jr. | 7 | $250K |
| Finley John David | 5 | $303K |
| Chuang Emil | 3 | — |
| Williams Donald Allen | 3 | — |
| Wei Binxian | 3 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PALI insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PALI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.